One of the first questions we hear from a new capsule buyer is:
“What is your minimum order quantity?”
It sounds like a simple question. In practice, one number rarely tells the whole story.
A 100-bottle ready-stock order, a 500-bottle private label project, and a fully custom capsule formula starting from around 1,000 bottles are three different types of business.
The capsule line is only one part of the calculation.
Raw material purchasing, formula complexity, capsule size, testing, bottles, labels, cartons, and supplier minimums can all affect the quantity that makes sense for a first order.
So before comparing MOQ numbers between manufacturers, it is worth asking a more useful question:
What exactly am I getting at this quantity, and what still needs to be developed, purchased, or tested separately?
The Same “MOQ” Can Mean Three Different Orders
At HEKONA, we look at the project first rather than applying one minimum to every capsule product.
| Order Type | Typical Starting Quantity | What It Means |
| Ready-stock trial order | From 100 bottles | Existing finished product for initial market testing |
| Private label using an established formula | From 500 bottles | Existing HEKONA formula with your brand label and packaging support |
| Fully custom capsule formula | Suitable projects generally from around 1,000 bottles | Formula, raw materials, capsule fit, testing, and packaging need to be reviewed before final MOQ is confirmed |
The third route needs the most explanation.
A factory may be able to produce 1,000 bottles, but that does not automatically mean every custom formula is practical at 1,000 bottles.
One specialty ingredient may only be available from the supplier in a much larger pack. A custom printed carton may have its own minimum. Testing can also make a very small custom batch expensive compared with the finished quantity.
For custom work, the MOQ is confirmed after the formula and purchasing conditions are reviewed.
A 100-Bottle Ready-Stock Order Is Not an R&D Sample
These two stages are often confused.
They are not the same.
A 100-bottle ready-stock order is a commercial trial order. The formula and production route already exist, so the brand can use a smaller quantity to test the market before committing to a larger purchase.
An R&D sample serves another purpose.
It may be used to review the formula direction, capsule appearance, shell preference, initial fill feasibility, or other technical points before commercial production.
A sample can look good and still need more work before it is ready for routine manufacturing.
For a custom capsule, the blend still has to work under production conditions. Powder flow, bulk density, moisture, particle size, and filling behavior can all affect the final result.
Sample approval tells us:
The product direction is acceptable.
Commercial production asks a different question:
Can the approved formula be made consistently under the agreed production specification?
That distinction matters on a first order.
The Capsule Line Is Often Not the Real MOQ Limit
Consider a brand asking for 500 bottles of a fully custom capsule.
The finished quantity sounds reasonable.
Then we review the formula and find a specialty botanical extract that is sold only in a pack much larger than the amount needed for 500 bottles.
The customer also wants a custom printed carton.
Now there are at least three different minimums in the same project:
the finished production quantity, the raw material purchase, and the packaging order.
The capsule line itself may be able to run the batch. The project may still not make commercial sense at 500 bottles.
This is why the real MOQ should be looked at in parts.
Brands should know how much finished product will be made, which ingredients create a larger purchasing commitment, what packaging minimums apply, and what happens to any unused material.
If the brand pays for excess raw material or packaging, there should be a clear agreement on ownership, storage, usable shelf life, and whether it can reasonably be carried into the next order.
A low finished-unit MOQ can become expensive if these details only appear after the quotation is accepted.
Fix the Product Before Asking for the Final Price
A reliable quote needs a reasonably stable product brief.
If the serving size changes today, the capsule count tomorrow, and the bottle quantity next week, the price will move with them.
These decisions are connected.
A higher active load may require a larger capsule or more capsules per serving.
More capsules per serving can change the bottle count, label directions, packaging size, and cost per serving.
For a first custom capsule project, we normally want to understand the practical basics:
the ingredient list, amount per serving, capsules per serving, target market, preferred shell, capsules per bottle, order quantity, and any excipient or allergen restrictions.
Not everything has to be final on day one.
But the open points should be clear.
That makes the quotation more useful and reduces avoidable changes later.
Two 500 mg Formulas May Not Fit the Same Capsule
This is one of the most common misunderstandings in capsule development.
Two formulas can both show “500 mg” and still need different capsule sizes.
The reason is simple: a capsule holds volume, not just weight.
Powders have different bulk densities.
A dense material may fit comfortably into a capsule at 500 mg. A lighter, bulkier botanical blend at the same weight may need a larger shell or more capsules per serving.
Flow matters too.
A powder that bridges, sticks, or absorbs moisture can behave differently during filling even if the theoretical weight looks fine on paper.
Multi-ingredient formulas raise more questions.
Do materials with very different particle sizes separate during handling?
Does the blend remain uniform?
If one active is present at a low level, how will distribution be controlled?
This is why capsule size should not be selected from milligrams alone.
When a formula is close to the physical limit of a capsule, the actual blend needs to be considered.
A Useful Trial Should Tell You What Was Learned
A trial is not valuable simply because the capsules look good.
It should give the development and production teams useful information.
Did the selected capsule size hold the target fill comfortably?
Did the powder flow as expected?
Was a small amount of formulation aid needed?
Did the capsule close properly?
Was fill weight reasonably consistent?
If the answer shows that the formula needs adjustment, that is not a failed trial.
It is much cheaper to discover a fill problem before labels and cartons are printed than after packaging has already been purchased.
For a first custom capsule order, written development feedback is usually more useful than a simple message saying:
“Sample approved.”
The goal is to know what is ready and what still needs work.
Low MOQ Does Not Mean Low Cost per Bottle
Small orders spread fixed project work across fewer units.
Formula review, sample work, line setup, cleaning, documentation, testing, and packaging preparation do not disappear because the order is smaller.
That is why a first order can have a lower total investment while still carrying a higher cost per bottle.
This is normal.
When comparing two quotations, the bottle price alone is not enough.
The brand should know what is included in product development, raw materials, manufacturing, testing, and packaging.
Trade terms should also be clear.
If the quote is based on factory pickup, freight, export documents, and destination-country clearance may be separate.
A very low unit price can look attractive until the missing items are added later.
The better comparison is:
What will I actually receive for this price, and what still needs to be paid for before the product is ready to sell?
Packaging Can Become the Real Minimum
The formula is only one part of a capsule product.
Packaging suppliers have their own minimums.
A standard bottle with a pressure-sensitive label normally gives a first order more flexibility than a custom-color bottle, special closure, or heavily customized printed carton.
That does not mean the first package should look basic or unprofessional.
It means the level of customization should match the stage of the brand.
For early market testing, it can make more sense to keep the product specification strong and use a packaging route that does not create unnecessary inventory.
Once sales become more predictable, the brand can move into deeper customization with less risk.
If a supplier requires more labels, bottles, or cartons than the first production run will use, this should be discussed before the purchase order is placed.
Who owns the remaining materials?
Can they be used for the next batch?
How long can they be stored?
Are there storage charges?
Those questions are part of the real MOQ too.
Testing and Documents Still Matter on a Small Order
A small commercial order still needs a defined product specification.
The final formula, raw material specifications, capsule shell, fill target, finished-product requirements, packaging, and artwork should all refer to the same approved product.
Testing also needs to be clear before production.
What is included in the quotation?
What is required for the target market?
Which results are used for batch release?
What will appear on the finished-product Certificate of Analysis?
If the product is intended for the United States, the project also needs to be reviewed against the applicable dietary supplement manufacturing and labeling requirements.
For other markets, documentation, registration, import, and label requirements should be checked against the destination country.
Doing this work properly on the first order makes the second order much easier.
If a raw material supplier, ingredient grade, capsule shell, fill weight, or packaging component changes later, the change should be reviewed against the approved product rather than treated as an invisible substitution.
A Good First Order Makes the Reorder Easier
The first order should do more than put product on the market.
It should give the brand a stable reference for the next purchase.
If the formula, raw material specifications, capsule format, packaging, testing scope, and production requirements are already controlled, the reorder starts from something real.
This is also why excess materials should be discussed from the beginning.
Can the remaining raw material still be used?
How much qualified packaging is left?
Will the next order have the same MOQ?
How long will raw material purchasing take?
Will testing be repeated?
How much production lead time should the brand allow?
These questions may not feel urgent when the first batch is still being developed.
They become important as soon as the product starts selling.
How HEKONA Handles Low-MOQ Capsule Projects
HEKONA has an annual hard-capsule production capacity of approximately 2 billion capsules.
That does not mean every brand needs to start with a large order.
The right starting quantity depends on the project.
For brands that want to test the market with an existing product, ready-stock commercial trial orders can start from 100 bottles.
For private label projects using an established HEKONA formula, orders can start from 500 bottles.
For fully custom capsule projects, suitable formulas generally start from around 1,000 bottles, subject to formula review, raw material minimums, capsule fit, testing, and packaging requirements.
R&D samples are handled separately from commercial orders.
For a custom project, we review the formula first.
We look at the serving size, expected capsule fit, raw material availability, and packaging requirements before confirming the commercial route.
If something still needs technical work, it is better to identify it before the brand commits to printed packaging or a production schedule.
The objective is not to make every MOQ as low as possible.
It is to find a starting quantity that still works for the formula, the cost structure, and the next order.
Before Placing Your First Capsule Order
A first order is easier to manage when the brand and manufacturer are working from the same version of the product.
Before commercial production, both sides should be aligned on the formula, serving size, capsule specification, finished quantity, packaging, testing scope, document requirements, and treatment of excess materials.
If something is still open, that should be visible too.
A small first order can be a sensible way to enter the market.
But “small” should refer to the inventory commitment.
It should not mean skipping the product development or quality work needed for a commercial product.
FAQ
Is the lowest MOQ always the best option for a new supplement brand?
No.
A smaller first order can reduce inventory exposure, but a custom formula may still require specialty raw materials, testing, or packaging with higher supplier minimums.
If the finished quantity is pushed too low, the unit cost may rise sharply or a large amount of unused material may remain.
The complete project matters more than the headline MOQ.
Why can HEKONA start some products from 100 bottles but not every custom formula?
The 100-bottle option applies to ready-stock commercial products.
The formula and production route already exist, so the brand can use a smaller quantity for initial market testing.
A fully custom product may need new raw materials, formula work, capsule-fit review, testing, and different packaging.
They are different order types.
Is a 100-bottle ready-stock order the same as an R&D sample?
No.
A 100-bottle ready-stock order is a commercial trial order.
An R&D sample is used during product development to review the formula, appearance, capsule fit, shell preference, or other technical points before commercial production.
They serve different purposes.
Can commercial production start as soon as the R&D sample is approved?
Not automatically.
Sample approval usually confirms the product direction.
Before commercial production, the formula may still need review for powder flow, bulk density, capsule fit, scale-up conditions, and the final commercial specification.
Why can two 500-bottle projects have different prices or minimums?
Because the bottle count is only one part of the project.
One formula may use readily available materials and standard packaging.
Another may require a specialty ingredient, additional testing, or custom cartons.
The finished quantity can be the same while the purchasing and manufacturing conditions are very different.
What should be confirmed before the capsule label is printed?
The label should match the approved commercial product, not an early development sample.
Before final printing, the formula, ingredient names, amount per serving, serving size, capsule count, directions, relevant warnings, net quantity, and final packaging specification should all be checked.
Final Note
Low MOQ capsule manufacturing works best when it gives a brand a manageable way to enter the market without creating unnecessary problems for the next order.
The key is to separate four different things:
ready-stock trial orders, private label using an established formula, fully custom development, and R&D samples.
Once those are separated, it becomes much easier to understand why one project can start from 100 bottles, another from 500 bottles, while a fully custom formula may need around 1,000 bottles or more before the project becomes practical.
For a new capsule project, HEKONA can review the formula, target serving, order quantity, capsule format, and packaging requirements before confirming the most suitable production route.
